Prostate Cancer Ireland

30/09/2026

https://prostatecancerireland.ie/ipcor-a-hugely-significant-project-for-prostate-cancer-patients-in-ireland/

Did you know there's a national research project tracking prostate cancer care in Ireland?

IPCOR, run by a team at UCD and funded by Movember, follows men through diagnosis, treatment, and long-term follow-up to help improve outcomes and quality of life.

It's already running in hospitals around the country, and several Prostate Cancer Ireland members sit on its patient advisory panel, making sure the patient voice is heard.

Find out what IPCOR does, what information it collects, and how it could shape prostate cancer treatment for years to come.

IPCOR – a hugely significant project for prostate cancer patients in Ireland by Prostate Cancer Ireland | Sep 30, 2026 | News, Research, Treatments What is IPCOR? IPCOR is a national, longitudinal clinical quality registry and biorepository focused on men undergoing investigation and treatment for...

28/09/2026

The Executive committee would like to thank Shelagh Cunningham and the members of Dun Laoghaire Golf Club for their generous donation

28/09/2026

The Executive committee of Prostate Cancer Ireland would like to thank Stephen McQuillan (Captain ) and the members of Concra Wood Golf Club Castleblayney for their generous donation

15/09/2026

20/08/2026

PRO-ACT study identifies that prostate cancer patients and their partners are often left 'suffering in silence' due to fractured post-treatment pathway. The PRO-ACT patient led study looked at the impact of prostate cancer treatment on sexual wellbeing, intimacy, mental health and quality of life. Read more here:

The PRO-ACT Research study by Prostate Cancer Ireland | Aug 19, 2026 | News, Patient Stories, Research, Support & Relationships What PRO-ACT looked at: PRO-ACT looked at the impact of prostate cancer treatment on sexual wellbeing, intimacy, mental health and quality of life and examined: how well pa...

11/08/2026

New study finds PSA below 0.2 ng/mL predicts longer survival in metastatic castration-sensitive prostate cancer, outperforming 90% PSA decline.

05/06/2026

Introducing our new name: Prostate Cancer Ireland

For over thirty years, Men Against Cancer (MAC) has been an understated but active presence in the lives of men diagnosed with prostate cancer in Ireland, and in the lives of those who love them. Founded in 1993, MAC began as a small group of men who understood, from personal experience, what it meant to face a prostate cancer diagnosis – and who believed that no one should have to face it alone.

That belief has never changed. But the organisation has grown, and the time has come for the name to grow with it.

Find out more at:
https://prostatecancerireland.ie/a-new-name-a-new-chapter-introducing-prostate-cancer-ireland/

15/05/2026

Proud to announce our new name, Prostate Cancer Ireland, and our new website at https://prostatecancerireland.ie

08/05/2026

The Alliance for Clinical Trials in Oncology is now enrolling patients in the ASPIRE trial (A032302)-a large-scale, phase III clinical study investigating whether adding chemotherapy to current standard treatments extends survival for men with advanced prostate cancer.